Pliant Therapeutics (PLRX) Cash & Equivalents (2019 - 2026)
Pliant Therapeutics (PLRX) recorded Cash & Equivalents of $24.88 million in Q2 2026, down 71.3% from $86.82 million a year earlier but up 12.1% from the prior quarter.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Pliant Therapeutics reported Cash & Equivalents of $45.45 million, down 36.2% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $71.19 million in FY2024 (+12.6%), $63.23 million in FY2023 (+87.7%), $33.69 million in FY2022 (-34.8%) and $51.67 million in FY2021 (+1.5%).
- Quarterly Cash & Equivalents has ranged from $22.19 million in Q1 2026 to $114.3 million in Q1 2024 over the past five years.
- On a year-over-year basis, Cash & Equivalents has declined for three consecutive quarters, with an average decline of 15.8% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 215.0% in Q1 2023, against a decline of 75.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $22.19 million (Q1 2026), $45.45 million (Q4 2025) and $93.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Pliant Therapeutics | 66.87 Mn | 66.87 Mn | - | 24.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.88 Mn |
| Mar 31, 2026 | 22.19 Mn |
| Dec 31, 2025 | 45.45 Mn |
| Sep 30, 2025 | 93.73 Mn |
| Jun 30, 2025 | 86.82 Mn |
| Mar 31, 2025 | 91.94 Mn |
| Dec 31, 2024 | 71.19 Mn |
| Sep 30, 2024 | 79.62 Mn |
| Jun 30, 2024 | 80.39 Mn |
| Mar 31, 2024 | 114.30 Mn |
| Dec 31, 2023 | 63.23 Mn |
| Sep 30, 2023 | 57.68 Mn |
| Jun 30, 2023 | 54.95 Mn |
| Mar 31, 2023 | 102.53 Mn |
| Dec 31, 2022 | 33.69 Mn |
| Sep 30, 2022 | 44.62 Mn |
| Jun 30, 2022 | 25.07 Mn |
| Mar 31, 2022 | 32.55 Mn |
| Dec 31, 2021 | 51.67 Mn |
| Sep 30, 2021 | 45.23 Mn |
API Access
Pliant Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();